Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1979 Jan;32(1):21–25. doi: 10.1136/jcp.32.1.21

Determination of antithrombin activity by an amidolytic and a clotting procedure.

A Frigola, S Angeloni, A R Cerqueti
PMCID: PMC1145561  PMID: 429575

Abstract

Plasma antithrombin activity was measured using an amidolytic method (substrate Chromozym TH) and a clotting method. The mean antithrombin values found in 76 hospital outpatients were 9.4 micronmol/min/ml with the amidolytic procedure and 100.1% of antithrombin activity with the clotting procedure. The two methods correlate fairly well (r = 0.85, P less than 0.01) and show satisfactory reproducibility. Coefficients of variation of 5.9% and 8.8% were obtained respectively with the amidolytic and the clotting procedures. In the presence of very high levels of fibrinogen degradation products, falsely elevated antithrombin activity levels were observed with the clotting procedure but the amidolytic method is essentially unaffected. It is concluded that both methods are suitable for determining antithrombin activity but a well-standardised amidolytic procedure has advantages.

Full text

PDF
21

Images in this article

23Fig. 2
on p.23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abildgaard U., Lie M., Odegård O. R. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Thromb Res. 1977 Oct;11(4):549–553. doi: 10.1016/0049-3848(77)90208-0. [DOI] [PubMed] [Google Scholar]
  2. Biggs R., Denson K. W., Akman N., Borrett R., Hadden M. Antithrombin 3, antifactor Xa and heparin. Br J Haematol. 1970 Sep;19(3):283–305. doi: 10.1111/j.1365-2141.1970.tb01627.x. [DOI] [PubMed] [Google Scholar]
  3. Blombäck M., Blombäck B., Olsson P., Svendsen L. The assay of antithrombin using a synthetic chromogenic substrate for thrombin. Thromb Res. 1974 Nov;5(5):621–632. doi: 10.1016/0049-3848(74)90052-8. [DOI] [PubMed] [Google Scholar]
  4. Carvalho A., Ellman L. Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function. Am J Med. 1976 Aug;61(2):179–183. doi: 10.1016/0002-9343(76)90167-4. [DOI] [PubMed] [Google Scholar]
  5. Collen D., Schetz J., de Cock F., Holmer E., Verstraete M. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. Eur J Clin Invest. 1977 Feb;7(1):27–35. doi: 10.1111/j.1365-2362.1977.tb01566.x. [DOI] [PubMed] [Google Scholar]
  6. Damus P. S., Hicks M., Rosenberg R. D. Anticoagulant action of heparin. Nature. 1973 Dec 7;246(5432):355–357. doi: 10.1038/246355a0. [DOI] [PubMed] [Google Scholar]
  7. EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
  8. Frigola A. Standardisation of a simple method for the determination of antithrombin activity. J Clin Pathol. 1977 Sep;30(9):881–883. doi: 10.1136/jcp.30.9.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gaffney P. J., Lord K., Brasher M., Kirkwood T. B. Problems in the assay of thrombin using synthetic peptides as substrates. Thromb Res. 1977 Apr;10(4):549–556. doi: 10.1016/0049-3848(77)90210-9. [DOI] [PubMed] [Google Scholar]
  10. Highsmith R. F., Rosenberg R. D. The inhibition of human plasmin by human antithrombin-heparin cofactor. J Biol Chem. 1974 Jul 25;249(14):4335–4338. [PubMed] [Google Scholar]
  11. Machovich R., Borsodi A., Blaskó G., Orakzai S. A. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor. Biochem J. 1977 Nov 1;167(2):393–398. doi: 10.1042/bj1670393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marciniak E., Farley C. H., DeSimone P. A. Familial thrombosis due to antithrombin 3 deficiency. Blood. 1974 Feb;43(2):219–231. [PubMed] [Google Scholar]
  13. Odegard O. R., Lie M., Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res. 1975 Apr;6(4):287–294. doi: 10.1016/0049-3848(75)90078-x. [DOI] [PubMed] [Google Scholar]
  14. Odegård O. R., Abildgaard U. Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiency. Scand J Haematol. 1977 Feb;18(2):86–90. doi: 10.1111/j.1600-0609.1977.tb02076.x. [DOI] [PubMed] [Google Scholar]
  15. Odegård O. R., Lie M., Abildgaard U. Antifactor Xa activity measured with amidolytic methods. Haemostasis. 1976;5(5):265–275. doi: 10.1159/000214145. [DOI] [PubMed] [Google Scholar]
  16. Osterud B., Miller-Andersson M., Abildgaard U., Prydz H. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X. Thromb Haemost. 1976 Apr 30;35(2):295–304. [PubMed] [Google Scholar]
  17. Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973 Sep 25;248(18):6490–6505. [PubMed] [Google Scholar]
  18. Sas G., Blaskó G., Bánhegyi D., Jákó J., Pálos L. A. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Thromb Diath Haemorrh. 1974 Sep 30;32(1):105–115. [PubMed] [Google Scholar]
  19. Villaneuva G. B., Danishefsky I. Evidence for a heparin-induced conformational change on antithrombin III. Biochem Biophys Res Commun. 1977 Jan 24;74(2):803–809. doi: 10.1016/0006-291x(77)90374-6. [DOI] [PubMed] [Google Scholar]
  20. Von Kaulla E., Von Kaulla K. N. Antithrombin 3 and diseases. Am J Clin Pathol. 1967 Jul;48(1):69–80. doi: 10.1093/ajcp/48.1.69. [DOI] [PubMed] [Google Scholar]
  21. Yin E. T., Wessler S., Stoll P. J. Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor. J Biol Chem. 1971 Jun 10;246(11):3712–3719. [PubMed] [Google Scholar]
  22. Zuck T. F., Bergin J. J., Raymond J. M., Dwyre W. R. Implications of depressed antithrombin-3 activity associated with oral contraceptives. Surg Gynecol Obstet. 1971 Oct;133(4):609–612. [PubMed] [Google Scholar]
  23. van der Meer J., Stoepman-van Dalen E. A., Jansen J. M. Antithrombin-3 deficiency in a Dutch family. J Clin Pathol. 1973 Jul;26(7):532–538. doi: 10.1136/jcp.26.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES